Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 4,959,700 | 4,978,700 | 4,644,700 | 5,121,300 | 4,875,600 |
| Cost of Goods | 1,236,900 | 1,218,400 | 1,192,700 | 1,253,100 | 1,267,000 |
| Gross Profit | 3,722,800 | 3,760,300 | 3,452,000 | 3,868,200 | 3,608,600 |
| Operating Expenses | 2,762,400 | 2,885,300 | 2,927,500 | 3,559,599 | 3,010,300 |
| Operating Income | 961,300 | 875,400 | 525,200 | 308,700 | 598,300 |
| Other Income | 86,500 | -195,700 | 92,700 | 204,900 | 57,200 |
| Pre-tax Income | 1,047,800 | 679,700 | 617,900 | 513,600 | 655,500 |
| Income Tax | 248,100 | 78,900 | 88,400 | 85,100 | 154,900 |
| Net Income Continuous | 799,700 | 600,800 | 529,500 | 428,500 | 500,600 |
| Net Income | $799,700 | $600,800 | $529,500 | $428,500 | $500,600 |
| EPS Basic Total Ops | 0.75 | 0.57 | 0.50 | 0.40 | 0.47 |
| EPS Basic Continuous Ops | 0.75 | 0.57 | 0.50 | 0.40 | 0.47 |
| EPS Diluted Total Ops | 0.75 | 0.56 | 0.50 | 0.40 | 0.47 |
| EPS Diluted Continuous Ops | 0.75 | 0.56 | 0.50 | 0.40 | 0.47 |
| EBITDA(a) | $1,319,600 | $1,243,900 | $882,700 | $648,101 | $940,700 |